F D C Ltd
NSE:FDC

Watchlist Manager
F D C Ltd Logo
F D C Ltd
NSE:FDC
Watchlist
Price: 478.05 INR 0.9% Market Closed
Updated: May 19, 2024

Relative Value

The Relative Value of one FDC stock under the Base Case scenario is hidden INR. Compared to the current market price of 478.05 INR, F D C Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FDC Relative Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
11
vs Industry
32
Median 3Y
3.2
Median 5Y
3.2
Industry
2.5
Forward
3.5
vs History
4
vs Industry
19
Median 3Y
23.1
Median 5Y
19.3
Industry
23.5
Forward
20.3
vs History
12
vs Industry
12
Median 3Y
29.3
Median 5Y
26
Industry
17.4
vs History
19
vs Industry
8
Median 3Y
67.4
Median 5Y
31.2
Industry
24.3
vs History
0
vs Industry
19
Median 3Y
2.7
Median 5Y
2.7
Industry
2.1
vs History
6
vs Industry
32
Median 3Y
2.9
Median 5Y
2.9
Industry
2.6
Forward
3.3
vs History
1
vs Industry
38
Median 3Y
4.5
Median 5Y
4.4
Industry
5.3
vs History
1
vs Industry
17
Median 3Y
17.7
Median 5Y
15.3
Industry
13.7
Forward
14.7
vs History
3
vs Industry
19
Median 3Y
20.7
Median 5Y
17.6
Industry
17.4
Forward
16.3
vs History
11
vs Industry
12
Median 3Y
27.4
Median 5Y
23.2
Industry
16.2
vs History
19
vs Industry
7
Median 3Y
57.1
Median 5Y
26.6
Industry
18.6
vs History
7
vs Industry
20
Median 3Y
3.1
Median 5Y
3.1
Industry
1.9

Multiples Across Competitors

FDC Competitors Multiples
F D C Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
F D C Ltd
NSE:FDC
77.8B INR 4.1 26.9 21.9 24.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
731.8B USD 20.4 119.2 58.4 66.4
DK
Novo Nordisk A/S
CSE:NOVO B
4T DKK 16.5 45.1 33.6 36.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
372.2B USD 4.3 9.7 11.9 15.6
US
Merck & Co Inc
NYSE:MRK
332.3B USD 5.4 144.1 35.9 58.5
UK
AstraZeneca PLC
LSE:AZN
187.7B GBP 5 37.6 174.5 278.3
CH
Roche Holding AG
SIX:ROG
189B CHF 3.2 16.4 9.3 11
CH
Novartis AG
SIX:NOVN
182.7B CHF 3.4 11.5 8.7 12.7
US
Pfizer Inc
NYSE:PFE
162.3B USD 2.9 -525.3 12.7 20.6
P/E Multiple
Earnings Growth
IN
F D C Ltd
NSE:FDC
Average P/E: 51.3
26.9
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
119.2
346%
DK
Novo Nordisk A/S
CSE:NOVO B
45.1
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
9.7
-21%
US
Merck & Co Inc
NYSE:MRK
144.1
7 453%
UK
AstraZeneca PLC
LSE:AZN
37.6
168%
CH
Roche Holding AG
SIX:ROG
16.4
26%
CH
Novartis AG
SIX:NOVN
11.5
15%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -525.3
680%

See Also

Discover More